Multidisciplinary management of advanced prostate cancer: Changing perspectives on referring patients and enhancing collaboration between oncologists and urologists in clinical trials

Michael A. Carducci, Peter R. Carroll, Matthew R. Smith, Robert S. DiPaola, Joel B. Nelson

Research output: Contribution to journalArticlepeer-review

Abstract

Prostate cancer traditionally was managed by monotherapy, and treatment was almost exclusively provided by the urologic surgeon. As ongoing clinical trials in advanced disease identify novel agents or combination therapies with good tolerability and potential survival benefits, multidisciplinary management may offer optimal care for men with high-risk prostate cancer, as it does for women with breast cancer. Patients with high-risk recurrent or metastatic disease should be informed of clinical trials for which they may be eligible.

Original languageEnglish (US)
Pages (from-to)18-22
Number of pages5
JournalUrology
Volume65
Issue number5 SUPPL.
DOIs
StatePublished - May 2005

ASJC Scopus subject areas

  • Urology

Fingerprint

Dive into the research topics of 'Multidisciplinary management of advanced prostate cancer: Changing perspectives on referring patients and enhancing collaboration between oncologists and urologists in clinical trials'. Together they form a unique fingerprint.

Cite this